2016;12(12):e1005978
It's reported here because it's part of the mechanistic case for AHK-Cu and hair, and because it's frequently quoted as a standalone benefit when it's really one component of the 2007 result
This article explains general peptide reconstitution principles, UK regulatory status, and critical safety considerations it does not constitute clinical advice or endorse self-administration
Scientific references Wu G, Fang YZ, Yang S, Lupton JR, Turner ND
The most extensively researched and clinically proven copper peptide is GHK-Cu, a tripeptide composed of glycine, L-histidine, and L-lysine bound to copper
Oral GnRH antagonists such as elagolix induce dose-dependent suppression of LH, FSH, and estradiol levels, reducing pain while minimizing severe hypoestrogenism